Natco Pharma Limited has informed the Exchange regarding a press release dated January 30, 2025, titled "NATCO announces approval of its ANDA for Everolimus tablets".
Press Release Jan 30 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from NATCO Pharma
- Press Release Nov 27 2024
- Press Release Nov 21 2024
- Press Release Sep 04 2024
- Press Release Aug 29 2024
- Press Release Jan 17 2024
Later from NATCO Pharma
- Natco Pharma Limited Press Release Feb 10 2025
- Press Release Apr 08 2025
- Press Release Jul 24 2025
- Press Release Aug 20 2025
- Press Release Sep 10 2025
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma